Carilex Medical (ROCO:7726) Net Margin %: -9.86% (As of Dec. 2025)


ROCO:7726 Carilex Medical Inc ROCO:7726
34 GF Score
Price NT$32.45
! 5 Warning Signs
View Full Analysis

What is Carilex Medical Net Margin %?

Carilex Medical ROCO:7726 +0.15% 34 Net Margin % is -9.86% as of Dec. 2025. GuruFocus rates ROCO:7726 with a GF Score™ of 34/100. The stock has 5 warning signs investors should review. Among 818 Medical Devices & Instruments companies, Carilex Medical ranks worse than 63.2% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Carilex Medical's Net Income for the six months ended in Dec. 2025 was NT$-18.4 Mil. Carilex Medical's Revenue for the six months ended in Dec. 2025 was NT$186.3 Mil. Therefore, Carilex Medical's net margin for the quarter that ended in Dec. 2025 was -9.86%.

The historical rank and industry rank for Carilex Medical's Net Margin % or its related term are showing as below:

ROCO:7726' s Net Margin % Range Over the Past 10 Years
Min: -8.56   Med: 8.48   Max: 15.29
Current: -8.56

ROCO:7726's Net Margin % is ranked worse than
63.2% of 818 companies
in the Medical Devices & Instruments industry
Industry Median: 2.06 vs ROCO:7726: -8.56

Carilex Medical  (ROCO:7726) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Carilex Medical Net Margin % Related Terms

Carilex Medical Net Margin % Historical Data

* Premium members only.

The historical data trend for Carilex Medical's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carilex Medical Net Margin % Chart

Carilex Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial 8.34 8.61 9.53 3.83 -8.56

Carilex Medical Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.26 5.06 2.48 -6.97 -9.86

ROCO:7726 vs ABT, SYK, MDT: Net Margin % Comparison

For the Medical Devices subindustry, Carilex Medical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Carilex Medical Net Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carilex Medical's Net Margin % distribution charts can be found below:

* The bar in red indicates where Carilex Medical's Net Margin % falls into.


ROCO:7726
34GF Score
Carilex Medical Inc ROCO:7726
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carilex Medical Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Carilex Medical's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-28.98/338.628
=-8.56 %

Carilex Medical's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-18.367/186.307
=-9.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -9.86% mean?
Carilex Medical (ROCO:7726) has a Net Margin % of -9.86% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Carilex Medical and its competitors. According to the industry distribution chart, Carilex Medical ranks #517 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 63.2%.
Is Carilex Medical's Net Margin % too high?
Carilex Medical's current Net Margin % is -9.86%. Based on the distribution chart, Carilex Medical ranks #517 out of 818 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Carilex Medical has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Carilex Medical's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Carilex Medical ranks #517 out of 818 companies for Net Margin %. This places Carilex Medical in the lower half of its industry. The industry median Net Margin % is 2.06. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.06, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Carilex Medical and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carilex Medical's current Net Margin % is -9.86%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carilex Medical stock overvalued right now?
Carilex Medical (ROCO:7726) has a current Net Margin % of -9.86%. The current Net Margin % is -9.86%. Carilex Medical's overall GF Score™ is 34/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Carilex Medical (ROCO:7726), the current Net Margin % is -9.86% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Carilex Medical Business Description

Address No.77, Keji 1st Road, Guishan District, Taoyuan, TWN, 33383
Carilex Medical Inc is a company engaged in the wound care industry by developing leading-edge technology in the prevention and treatment of wounds. Their expertise is in research and development, manufacturing, and quality control and assurance allow us to provide unparalleled products in wound care management in the form of comprehensive product lines proven to prevent and manage pressure sores and wounds. They offer products in the form of Support Surfaces, Chair Cushion and Negative Pressure Wound Therapy.
34GF Score

Get the complete analysis for ROCO:7726

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$32.45
Price